{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "c.157G>A (p.Ala53Thr)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "PCR and RT-PCR with RFLP Analysis",
      "Material used": {
        "Material Source": "Patients Derived Material and Cell line",
        "Material Name": "Blood samples and Lymphoblastoid Cell Lines",
        "Description": "Blood samples from a PD patient and controls, and EBV-transformed lymphoblastoid cell lines established from peripheral blood lymphocytes."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Monoallelic expression documented with silencing of the p.Ala53Thr allele in the patientâ€™s lymphoblastoid cell line and blood mRNA."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal control DNA and RNA used for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Presence of bands corresponding to both alleles in RT-PCR digests.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Absence of bands corresponding to the mutant allele in RT-PCR digests, indicating monoallelic expression.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Real-Time PCR",
      "Material used": {
        "Material Source": "Patients Derived Material and Cell line",
        "Material Name": "Blood samples and Lymphoblastoid Cell Lines",
        "Description": "RNA extracted from blood cells and lymphoblastoid cell lines of the patient and controls for mRNA quantification."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased SNCA mRNA levels in the patient (14-35% higher in lymphoblastoid cells and twofold in blood cells) compared to controls, despite silencing of the mutant allele."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Multiple experiments performed with RNA from freshly drawn blood cells from the patient and four different controls."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "RNA from normal control individuals used for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "SNCA mRNA levels comparable to control individuals (65.1-86.2% of patient levels in lymphoblastoid cells).",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "SNCA mRNA levels significantly higher than control individuals (14-35% higher in lymphoblastoid cells, twofold in blood cells).",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Epigenetic Modification Assays",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Lymphoblastoid Cell Lines",
        "Description": "Lymphoblastoid cell lines treated with 5-azadC, 4-PBA, and TSA to investigate epigenetic silencing mechanisms."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "complete loss-of-function",
          "Result Description": "Silencing of the p.Ala53Thr allele due to histone modifications, reactivated by 4-PBA and TSA but not by 5-azadC, indicating no DNA methylation involvement."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Untreated control flask used for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Presence of bands corresponding to both alleles after treatment.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Absence of bands corresponding to the mutant allele before treatment, with reactivation after specific treatments.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "CpG Methylation Analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "Lymphoblastoid Cell Lines",
        "Description": "DNA from lymphoblastoid cell lines used to analyze methylation status of the SNCA gene CpG island."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "No methylation detected in the CpG island of the SNCA gene in the patient or controls, indicating silencing of p.Ala53Thr is not due to DNA methylation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "DNA from normal control individuals used for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No methylation detected in CpG sites.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Methylation detected in CpG sites.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Copy Number Variation (CNV) Analysis",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Genomic DNA",
        "Description": "Genomic DNA from the patient used for CNV analysis with Affymetrix GeneChip Mapping 250K arrays."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "No amplification or deletion of the SNCA gene detected; two copies of all 19 SNPs present."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not described in the literature."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Two copies of SNCA gene SNPs detected.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "More or less than two copies of SNCA gene SNPs detected.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}